Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
02/03/2023* 07:30 EST Earnings Call Q4 2022 -- -- --
02/03/2023* -- Results Q4 2022 -- 0.31 --
10/28/2022 08:00 EST Earnings Call Q3 2022 -- -- --
10/28/2022 -- Results Q3 2022 0.34 0.33 2.98%
07/29/2022 08:00 EST Earnings Call Q2 2022 -- -- --
07/28/2022 -- Results Q2 2022 0.37 0.38 -1.46%
04/29/2022 07:30 EST Earnings Call Q1 2022 -- -- --
04/28/2022 -- Results Q1 2022 0.38 0.36 7.02%
*Estimated Date/Time

Earnings

Next Report Date 02/03/2023 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 10/28/2022
Beat/Miss Upgrade
Return Since 11.55%
Last FQE 09/30/2022
Next FQE 12/30/2022

Profile

Edit
Avantor Inc is involved in providing products and services to biopharma, healthcare, education and government, and advanced technologies and applied materials industries. The company's offerings include materials and consumables, equipment and instrumentation and services and specialty procurement. Its brand profile consists of NuSil, RANKEM, POCH, BeneSphera, and Macron Fine Chemicals among others. The firm operates in three geographical segments namely Americas, Europe, and AMEA. It generates a majority of its revenue from the Americas.
URL https://www.avantorsciences.com
Investor Relations URL https://ir.avantorsciences.com
HQ State/Province Pennsylvania
Sector Basic Materials
Industry Specialty Chemicals
Equity Style Mid Cap/Blend
Next Earnings Release Feb. 03, 2023 (est.)
Last Earnings Release Oct. 28, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0.00%
Forward Yield --
Payout Ratio 7.61%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
--
--
--
--
--
55.10%
49.70%
-49.12%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-14.29%
-4.67%
56.21%
50.20%
-38.89%
-3.31%
105.6%
59.76%
17.29%
-37.95%
10.71%
-10.39%
14.13%
-25.28%
7.57%
72.15%
32.75%
-48.50%
73.49%
77.89%
-40.62%
28.92%
7.63%
42.32%
-16.26%
-12.01%
9.58%
35.02%
0.91%
9.43%
5.08%
37.67%
4.76%
As of November 25, 2022.

Profile

Edit
Avantor Inc is involved in providing products and services to biopharma, healthcare, education and government, and advanced technologies and applied materials industries. The company's offerings include materials and consumables, equipment and instrumentation and services and specialty procurement. Its brand profile consists of NuSil, RANKEM, POCH, BeneSphera, and Macron Fine Chemicals among others. The firm operates in three geographical segments namely Americas, Europe, and AMEA. It generates a majority of its revenue from the Americas.
URL https://www.avantorsciences.com
Investor Relations URL https://ir.avantorsciences.com
HQ State/Province Pennsylvania
Sector Basic Materials
Industry Specialty Chemicals
Equity Style Mid Cap/Blend
Next Earnings Release Feb. 03, 2023 (est.)
Last Earnings Release Oct. 28, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
SYNB 129830.0 USD 4.20%
PARMX 176.54M USD 2.81%
MEDI 51349.00 USD 2.02%
CII 13.84M USD 1.71%
TDB3093 44.19M USD 1.70%
MXMGX 23.93M USD 1.66%
GRX 4.739M USD 1.63%
PMEGX 59.56M USD 1.31%
RRMGX 323.40M USD 1.26%
FVUSA04AZ9 57.76M USD 1.25%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Nasdaq Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter AVTR Tweets